Skip to content

Treatment of Schizophrenia Through Internet-Based Psychoeducation

Schizophrenia Patient and Family Continuity of Care

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00051233
Enrollment
40
Registered
2003-01-08
Start date
2003-01-31
Completion date
2005-01-31
Last updated
2014-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia

Brief summary

The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.

Detailed description

This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being. Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

Interventions

PROCEDUREWorld Wide Web-Based Psychoeducation

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* DSM-IV diagnosis of schizophrenia or schizoaffective disorder * At least 4 hours/week in-person contact with a family member * Primary caregiver with a telephone * Patient and primary caregiver speak and read English

Exclusion criteria

* Enrolled in another clinical trial * Evidence of organic brain syndrome * Current alcohol or substance abuse that could explain the presenting index psychotic episode * DSM-IV diagnosis of psychoactive substance dependency

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026